OpenVSafe by OpenVAERS
Search V-safe

3GN-31230-56423

4 vaccinations 17 coded responses 48 check-ins 17 free-text entries 3 call cases
Sex
Female
Age at first dose
51-55
ZIP prefix
606 / IL
Registered
2020-12-31
Relationship
Self
Race
Native Hawaiian or other Pacific Islander
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-30
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-31
    Registered in v-safe
  3. 2020-12-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activities
    Adult check-in
  4. 2020-12-31
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  5. 2021-01-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-01-01
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  7. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Chills, Fatigue or tiredness
    Adult check-in
  8. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-01-05
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-01-06
    Survey response — day 7, dose 1
    MedDRA: Lymphadenopathy — Feeling: Fair
    Free text: Lymphadenopathy (L) supraclavicular
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-01-15
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-01-20
    Dose 2 — Pfizer-BioNTech
  14. 2021-01-21
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-01-22
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: Lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-01-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain
    Free text: Lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-01-24
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain
    Free text: Lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-01-25
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-01-26
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-01-27
    Survey response — day 7, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-02-10
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-19
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-24
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-03-03
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-21
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-07-21
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-10-02
    Dose 3 — Pfizer-BioNTech
  28. 2021-10-04
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  29. 2021-10-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  30. 2021-10-06
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  31. 2021-10-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  32. 2021-10-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  33. 2021-10-09
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2021-10-16
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  35. 2021-10-25
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-11-01
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  37. 2021-11-06
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-11-13
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  39. 2022-01-01
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  40. 2022-04-02
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  41. 2022-04-30
    Dose 4 — Pfizer-BioNTech
  42. 2022-05-01
    Survey response — days 1–6 daily, dose 4
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Supraclavicular lymph node enlargement and pain
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-05-02
    Survey response — days 1–6 daily, dose 4
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain · Fatigue or tiredness
    Free text: Supraclavicular lymph node swelling and pain
    MedDRA releases: 2024-11 · check-in free text available
  44. 2022-05-03
    Survey response — days 1–6 daily, dose 4
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good
    Free text: Supraclavicular and axillary lymph node enlargement and pain on side where vaccinated
    MedDRA releases: 2024-11 · check-in free text available
  45. 2022-05-04
    Survey response — days 1–6 daily, dose 4
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good
    Free text: Supraclavicular and axillary lymph node enlargement and pain
    MedDRA releases: 2024-11 · check-in free text available
  46. 2022-05-05
    Survey response — days 1–6 daily, dose 4
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good
    Free text: Supraclavicular and axillary enlargement and pain
    MedDRA releases: 2024-11 · check-in free text available
  47. 2022-05-06
    Survey response — days 1–6 daily, dose 4
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good
    Free text: Supraclavicular and axillary lymph node enlargement and pain
    MedDRA releases: 2024-11 · check-in free text available
  48. 2022-05-07
    Survey response — day 7, dose 4
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good
    Free text: Supraclavicular and axillary lymph node enlargement and pain
    MedDRA releases: 2024-11 · check-in free text available
  49. 2022-05-14
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  50. 2022-05-21
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  51. 2022-05-28
    Survey response — day 28, dose 4
    MedDRA: Cough, Headache, Malaise, Rhinitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Headaches, cough, rhinitis, malaise
    MedDRA releases: 2024-11 · check-in free text available
  52. 2022-05-28
    Report sent to call center — day 28, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  53. 2022-05-31
  54. 2022-06-06
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  55. 2022-06-11
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  56. 2022-07-30
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  57. 2022-10-29
    Survey response — 6 months, dose 4
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Lymphadenopathy Supraclavicular side If vaccination
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-30Pfizer-BioNTech
22021-01-20Pfizer-BioNTech
32021-10-02Pfizer-BioNTech No
42022-04-30Pfizer-BioNTech No

Call center

3 call center cases

1 unsuccessful · 2 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — day 7, dose 1

2021-01-06

Systemic reaction (other): Lymphadenopathy (L) supraclavicular

Release 2 — days 1–6 daily, dose 2

2021-01-21

Systemic reaction (other): Lymphadenopathy

2021-01-22

Systemic reaction (other): Lymphadenopathy

2021-01-23

Systemic reaction (other): Lymphadenopathy

2021-01-24

Systemic reaction (other): Lymphadenopathy

2021-01-25

Systemic reaction (other): Lymphadenopathy

2021-01-26

Systemic reaction (other): Lymphadenopathy

Release 2 — day 7, dose 2

2021-01-27

Systemic reaction (other): Lymphadenopathy

Release 11 — days 1–6 daily, dose 4

2022-05-01

Systemic reaction (other): Supraclavicular lymph node enlargement and pain

2022-05-02

Systemic reaction (other): Supraclavicular lymph node swelling and pain

2022-05-03

Systemic reaction (other): Supraclavicular and axillary lymph node enlargement and pain on side where vaccinated

2022-05-04

Systemic reaction (other): Supraclavicular and axillary lymph node enlargement and pain

2022-05-05

Systemic reaction (other): Supraclavicular and axillary enlargement and pain

2022-05-06

Systemic reaction (other): Supraclavicular and axillary lymph node enlargement and pain

Release 11 — day 7, dose 4

2022-05-07

Systemic reaction (other): Supraclavicular and axillary lymph node enlargement and pain

Release 11 — day 28, dose 4

2022-05-28

Symptoms: Headaches, cough, rhinitis, malaise

Release 12 — 6 months, dose 4

2022-10-29

Symptoms: Lymphadenopathy Supraclavicular side If vaccination

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDHeadache · · ✓
SDLymphadenopathy · · ✓
SDMalaise · · ✓
SDRhinitis · · ✓
SROLymph node pain · · ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…